Reports Q3 revenue $62.7M, consensus $61.72M. “Our financial performance this quarter exceeded the high end of our guidance on revenue, adjusted net income, and adjusted EBITDA,” said Kevin Coop, CEO of Definitive Healthcare (DH). “We experienced an improvement in expansion sales compared to Q2, and were pleased to welcome back several former customers, who either saw improvements in their financial situations or recognized the strategic value they were missing by not having access to our data and solutions. While it’s still early, we view these dynamics as promising indicators of momentum ahead.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DH:
- Definitive Healthcare Announces CFO Departure and Stock Buyback
- Definitive Healthcare launches Monocl Conferences solution
- Definitive Healthcare launches Market Forecast solution
- Definitive Healthcare initiated with a Buy at BTIG
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
